Can a 12-Week blood thinner regimen shield patients from Life-Threatening clots?
NCT ID NCT05089227
Summary
This study is testing whether taking preventive blood thinners for 12 weeks can stop dangerous blood clots from forming in people with autoimmune hemolytic anemia (AIHA), a rare condition where the immune system attacks red blood cells. People with AIHA have a much higher risk of clots, especially in the first few months after diagnosis. The trial will compare the clot rate in patients receiving the extended blood thinner treatment to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.